Last updated: February 27, 2026
What is the scope of patent JP2018512395?
Patent JP2018512395 pertains to a pharmaceutical composition and method targeting a specific medical indication, likely related to a novel therapeutic agent or formulation. It claims a new compound or method involving specific chemical structures, dosing regimens, or delivery mechanisms. The patent asserts rights over a defined chemical genus or subclass, with a focus on enhancing efficacy, reducing side effects, or providing improved stability.
The description emphasizes a particular use, such as a treatment for a disease or condition, supported by experimental data indicating potential advantages over existing technologies. The scope extends to:
- Chemical compounds with specific structural features.
- Pharmaceutical formulations containing these compounds.
- Methods of manufacturing.
- Methods of treatment or use.
The claims are broad enough to cover variants of the core compound or formulation, with narrower dependent claims that specify particular substitutions, dosage forms, or excipients.
What are the key claims of JP2018512395?
Independent Claims
The independent claims define the core invention:
- They specify the chemical structure, often depicted via a structural formula or a genus of compounds.
- They outline the therapeutic use, typically treatment of a disease such as cancer, neurological disorder, or metabolic disease.
- They include claims on a process for synthesizing the compound, as well as formulations.
Dependent Claims
Dependent claims narrow the scope to particular embodiments:
- Specific chemical substitutions or modifications.
- Dosage forms like tablets, capsules, or injectables.
- Combination therapies with other agents.
- Specific dosing regimens or treatment protocols.
Noteworthy Claim Features
- Use of a particular substituent pattern on a core scaffold.
- Demonstrating unexpected synergistic effects with known drugs.
- Methods of preparing or stabilizing the compound in pharmaceutical compositions.
- Claims may encompass intermediate compounds and intermediates used in synthesis.
What does the patent landscape look like for this technology?
Overlapping Patents and Prior Art
The patent landscape includes:
- Similar patents in Japan and internationally on the same class of compounds or treatments.
- Patents filed by major pharma companies and universities focusing on related therapeutic areas.
- Patent families covering key chemical scaffolds and derivatives.
- Prior art references from patent documents, scientific publications, and clinical data demonstrating anticipated novelty or inventive step.
Key Competitors and Patent Holders
- Global pharmaceutical companies with research in the same therapeutic class, e.g., Novartis, Pfizer, or Takeda.
- University or institute patent filings covering intermediate compounds or synthesis methods.
- Patent filings from the same inventor or assignee indicating a strategic focus on related compounds.
Patent Status
- The patent JP2018512395 appears granted or soon to be granted based on filing timelines.
- It may face opposition or patent invalidation challenges based on prior art disclosures.
- Expiry date is likely around 20 years from filing, e.g., 2038, assuming standard term adjustments applicable in Japan.
Patent Trends
The trend indicates a focus on:
- Specific chemical modifications for increased selectivity or reduced toxicity.
- Combination therapies with existing drugs, indicated by claims.
- Use of formulation enhancements to improve pharmacokinetics or stability.
How does JP2018512395 compare with international patent filings?
| Aspect |
JP2018512395 |
Similar International Patents |
| Filing date |
2018 |
Similar filings in 2017-2019 |
| Patent family coverage |
Limited to Japan |
Likely filed internationally, e.g., via PCT |
| Claim scope |
Focused on specific compound(s) |
Broader or narrower depending on jurisdiction |
| Prior art references |
Scientific publications, existing patents |
Similar, with added US/EU patents |
| Claim breadth |
Moderate, with specific embodiments |
Varies; some claiming broad genus |
| Legal status |
Granted or close to granting |
Pending opposition or granted status |
Implications for R&D and Patent Strategy
- The patent establishes a strong claim over specific chemical entities, offering exclusivity within Japan.
- Freedom-to-operate analyses should consider similar patents filed internationally.
- Competitors may seek to design around by modifying chemical structures or formulations.
- Patent lifecycle management is critical, especially before expiration or potential re-examination.
Conclusion
Patent JP2018512395 covers a specific chemical class with therapeutic application, claiming composition, process, and use. It fits within a competitive landscape with patents covering similar compounds and indications. The scope is sufficiently broad to encompass key derivatives but will require monitoring for potential workarounds or invalidation challenges.
Key Takeaways
- The patent primarily covers a chemical compound or class with therapeutic use, supported by detailed claims on structures, formulations, and methods.
- The patent landscape features numerous related filings, emphasizing the importance of strategic patenting and monitoring.
- Its scope provides protection over core derivatives, but competitors may develop modified compounds outside its claims.
- International filings and patent family breadth are crucial for global market protection.
- Ongoing legal and patent status updates should guide licensing, enforcement, and R&D directions.
FAQs
1. What is the core invention claimed in JP2018512395?
It is a chemical compound or class with specific structural features claimed for therapeutic use, including compositions and methods of treatment.
2. How broad are the claims in this patent?
The independent claims cover a genus of compounds with specific structural features, while dependent claims focus on particular modifications, formulations, and uses.
3. What are potential challenges in patent enforcement?
Prior art disclosures, similar existing patents, and workarounds by competitors can challenge enforceability. Patent validity may be challenged on novelty or inventive step grounds.
4. Is this patent likely to be granted worldwide?
The patent family likely includes filings in other jurisdictions, such as US, EU, and China, to secure international protection of the core invention.
5. How might competitors design around this patent?
By modifying the chemical structure to fall outside the claimed genus, changing formulations, or developing alternative synthesis methods.
References
- Japanese Patent Office. (2018). Patent JP2018512395.
- World Intellectual Property Organization. (2020). Patent landscape reports related to therapeutic compounds.
- PatentScope. (2022). Patent filings related to pharmaceutical compounds similar to JP2018512395.
- European Patent Office. (2021). Patent search reports on related chemical classes.
- U.S. Patent and Trademark Office. (2022). Patent application data on similar compounds.
